|
IBRX
|
ImmunityBio, Inc.
|
US
|
NASDAQ
|
|
IFRX
|
InflaRx N.V.
|
US
|
NASDAQ
|
|
IMNM
|
Immunome, Inc.
|
US
|
NASDAQ
|
|
IMTX
|
Immatics N.V.
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
US
|
NASDAQ
|
|
INDP
|
Indaptus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
INMB
|
INmune Bio Inc.
|
US
|
NASDAQ
|
|
IOBT
|
IO Biotech, Inc.
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
IPHA
|
Innate Pharma S.A.
|
US
|
NASDAQ
|
|
JANX
|
Janux Therapeutics, Inc.
|
US
|
NASDAQ
|
|
JNCE
|
Jounce Therapeutics, Inc.
|
US
|
NASDAQ
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MBIO
|
Mustang Bio, Inc.
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NKTX
|
Nkarta, Inc.
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OABI
|
OmniAb, Inc.
|
US
|
NASDAQ
|
|
PCRX
|
Pacira Pharmaceuticals, Inc.
|
US
|
NASDAQ
|